Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akero Therapeutics, Inc. - Common Stock (NQ:AKRO)

54.74 UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 54.74
Bid (Size) 54.60 (4,900)
Ask (Size) 54.70 (24,500)
Prev. Close 54.74
Today's Range 54.74 - 54.74
52wk Range 45.17 - 54.74
Shares Outstanding 50,086,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

52-Week Range
54.74
45.1752W Low 54.7452W High

Akero Therapeutics, Inc. - Common Stock (AKRO) traded between $45.17 and $54.74 over the past 52 weeks and last traded at $54.74.

Past 12 Months
N/A
N/A
N/A
N/A
N/A
+17.6%
1W  
1M  
3M  
6M  
YTD  
1Y +$8.19

AKRO was +17.6% over the past year.

12 Months vs Market
AKRO
+17.6%
DIA
+9.9%
SPY
+15.1%
QQQ
+24.3%
IWM
+16.2%

Over the past 12 months AKRO returned +17.6% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.2%.

Volume & Liquidity
1Y
2.7M

More News

Read More
News headline image
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗
Via Stocktwits
News headline image
Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
From Akero Therapeutics Inc.
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages AL, FFWM, AKRO, HNI Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qorvo, Inc. (Nasdaq – QRVO), First Foundation Inc. (NYSE – FFWM), Akero Therapeutics, Inc. (Nasdaq – AKRO), CoreCard Corporation (NYSE – CCRD)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Investigates AKRO, CCRD, PBBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE – AL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Omeros Catapults Almost 150% On A Surprise $2.1 Billion Deal With Novo Nordisk ↗
Via Investor's Business Daily
News headline image
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
This Keysight Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
Via Benzinga
News headline image
Wall Street Pulls Back as Earnings Season Kicks Off; PepsiCo, Delta, and Costco Defy the Trend ↗
Via Chartmill
Topics Stocks
News headline image
Why Akero Therapeutics Stock Trounced the Market on Thursday ↗
Via The Motley Fool
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today ↗
Via Stocktwits
News headline image
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates AKRO, CCRD, AL, PBBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Akero Therapeutics, Inc. (Nasdaq - AKRO), CoreCard Corporation (NYSE - CCRD), PB Bankshares, Inc. (Nasdaq - PBBK), Air Lease Corporation (NYSE - AL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Tilray Brands Posts Upbeat Results, Joins Byrna Technologies, Delta Air Lines And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion ↗
Via Benzinga
News headline image
Novo Nordisk Bulks Up Its Obesity-Tied Portfolio With $4.7 Billion Buyout ↗
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire

Frequently Asked Questions

Is Akero Therapeutics, Inc. - Common Stock publicly traded?
Yes, Akero Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Akero Therapeutics, Inc. - Common Stock trade on?
Akero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Akero Therapeutics, Inc. - Common Stock?
The ticker symbol for Akero Therapeutics, Inc. - Common Stock is AKRO on the Nasdaq Stock Market
What is the current price of Akero Therapeutics, Inc. - Common Stock?
The current price of Akero Therapeutics, Inc. - Common Stock is 54.74
When was Akero Therapeutics, Inc. - Common Stock last traded?
The last trade of Akero Therapeutics, Inc. - Common Stock was at 12/08/25 04:00 PM ET
What is the market capitalization of Akero Therapeutics, Inc. - Common Stock?
The market capitalization of Akero Therapeutics, Inc. - Common Stock is 2.74B
How many shares of Akero Therapeutics, Inc. - Common Stock are outstanding?
Akero Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.